| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc. (RVMD) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. RVMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $385.06M | - | |
| Other | 278.6K | $45.87M | - | |
| Other | 232.5K | $38.27M | - | |
| COO | 119.9K | $19.74M | - | |
| ? | 96.6K | $15.90M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2024 | Cislini Jeff | General Counsel | Sell | 2,000 | $38.47 | $76,939.60 | -3.9% | +15.6% | -2.4% | |
| Jun 25, 2024 | Kelsey Stephen Michael46 | See Remarks | Sale+OE | 16,667 | $39.06 | $650,951.62 | -3.0% | +9.8% | -1.1% | |
| Jun 17, 2024 | Goldsmith Mark A52 | See Remarks | Sell | 11,950 | $37.39 | $446,769.87 | -3.7% | +20.1% | +5.5% | |
| Jun 17, 2024 | Anders Jack47 | Chief Financial Officer | Sell | 1,893 | $37.39 | $70,774.73 | -1.8% | +20.1% | +5.5% | |
| Jun 17, 2024 | Horn Margaret A48 | Chief Operating Officer | Sell | 4,415 | $37.39 | $165,063.61 | -3.1% | +20.1% | +5.5% | |
| Jun 17, 2024 | Kelsey Stephen Michael46 | See Remarks | Sell | 3,349 | $37.39 | $125,209.06 | -1.2% | +20.1% | +5.5% | |
| Jun 17, 2024 | Cislini Jeff | General Counsel | Sell | 1,757 | $37.39 | $65,689.66 | -3.3% | +20.1% | +5.5% | |
| Jun 17, 2024 | Wei Lin | Chief Medical Officer | Sell | 5,589 | $37.39 | $208,954.27 | -7.3% | +20.1% | +5.5% | |
| Jun 3, 2024 | Goldsmith Mark A52 | See Remarks | Sale+OE | 7,500 | $39.99 | $299,942.36 | -0.8% | +3.5% | +1.0% | |
| May 21, 2024 | Cislini Jeff | General Counsel | Sell | 1,500 | $39.11 | $58,670.87 | -1.4% | +10.1% | -2.3% |